Browse > Article
http://dx.doi.org/10.5667/CellMed.2020.0021

COVID-19: An overview of current scenario  

Malik, Jonaid Ahmad (National Institute of Pharmaceutical Education and Research)
Maqbool, Mudasir (Department of Pharmaceutical Sciences, University of Kashmir)
Publication Information
CELLMED / v.10, no.3, 2020 , pp. 21.1-21.8 More about this Journal
Abstract
Over a span of few decades, the world has seen the emergence of new viruses that have posed serious problems to global health .COVID-19 is a major pathogenic threat to the modern world that primarily shoots the respiratory system of human beings. Wuhan which is the capital city of Hubei, China was the first place in the world where first cases of COVID-19 emerged and the scores of cases significantly increased at an immense rate leading to city isolation and establishment of new specially designed hospitals. SARS-CoV had emerged from bats in china (2002) and MERS-CoV from camels transmitted via bats in Middle East (2012) where the previous versions of COVID-19 took place. Infections with SARS-CoV-2 are now widespread, like Nuclear Chain Reaction (NRC). In this review we will discuss the COVID-19 origin, transmission, incubation, diagnosis and therapies available at the present scenario.
Keywords
COVID-19; SARS-CoV-2; therapies; diagnosis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J Microbiol Biotechnol. 2020;30(3): 313-324.   DOI
2 Al-Tawfiq JA, Momattin H, Dib J, Memish ZA.Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. International Journal of Infectious Diseases. 2014;20: 42-46.   DOI
3 Anderson G, Maes M, Markus RP, Rodriguez M. Ebola virus: melatonin as a readily available treatment option. Journal of medical virology. 2015;87(4): 537-543.   DOI
4 Andre FE. The future of vaccines, immunisation concepts and practice. Vaccine. 2001;19(17-19): 2206-2209.   DOI
5 Annan A, Baldwin HJ, Corman VM, Klose SM, Owusu M, Nkrumah EE, et al. Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe. Emerging infectious diseases. 2013; 19(3): 456.   DOI
6 Anonymous. WORLDOMETERS, YNM, Available at: https://www.worldometers.info/coronavirus/
7 Backer J, Klinkenberg D, Wallinga J. The incubation period of 2019-nCoV infections among travellers from Wuhan. China. medRxiv. 2020(27.20018986).
8 Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virology journal. 2005; 2(1): 69.   DOI
9 Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. The Lancet. 2020a; 395(10223): 470-473.   DOI
10 Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020b; 323(11): 1061-1069.   DOI
11 Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell research. 2020c; 30(3): 269-271.   DOI
12 Wang Q-L, Yang L, Peng Y, Gao M, Yang M-S, Xing W, et al. Ginsenoside Rg1 regulates SIRT1 to ameliorate sepsis-induced lung inflammation and injury via inhibiting endoplasmic reticulum stress and inflammation. Mediators of inflammation. 2019.
13 Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. Journal of medical virology.2020d; 92(4): 441-447.
14 Wang Y, Wang W, Xu L, Zhou X, Shokrollahi E, Felczak K, et al. (2016). Cross talk between nucleotide synthesis pathways with cellular immunity in constraining hepatitis E virus replication. Antimicrobial agents and chemotherapy. 2016; 60(5):2834-2848.   DOI
15 Wu C-Y, Jan J-T, Ma S-H, Kuo C-J, Juan H-F, Cheng Y-SE, et al. Small molecules targeting severe acute respiratory syndrome human coronavirus. Proceedings of the National Academy of Sciences. 2004; 101(27):10012-10017.   DOI
16 Wu X, Ji H, Wang Y, Gu C, Gu W, Hu L, et al. Melatonin alleviates radiation-induced lung injury via regulation of miR-30e/NLRP3 Axis. Oxidative medicine and cellular longevity. 2019.
17 Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223): 514-523.   DOI
18 Bai Y, Yao L, Wei T, Tian F, Jin D-Y, Chen L, et al. Presumed asymptomatic carrier transmission of COVID-19. Jama. 2020; 323(14): 1406-1407.   DOI
19 Ben-Nathan D, Maestroni G, Lustig S, Conti A. Protective effects of melatonin in mice infected with encephalitis viruses. Archives of virology. 1995;140(2): 223-230.   DOI
20 Boga JA, Coto-Montes A, Rosales-Corral SA, Tan DX, Reiter RJ. Beneficial actions of melatonin in the management of viral infections: a new use for this "molecular handyman"? Reviews in medical virology. 2012;22(5): 323-338.   DOI
21 Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. The Lancet infectious diseases. 2020a;20(4): 398-400.   DOI
22 Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet. 2020b;395(10223): 507-513.   DOI
23 Chen Y, Chan K-H, Kang Y, Chen H, Luk HK, Poon RW, et al. A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus. Emerging microbes & infections. 2015;4(1): 1-5.
24 Cheng Y, Wong R, Soo Y, Wong W, Lee C, Ng M, et al. (2005). Use of convalescent plasma therapy in SARS patients in Hong Kong. European Journal of Clinical Microbiology and Infectious Diseases. 2005;24(1): 44-46.   DOI
25 Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Eurosurveillance. 2020;25(5): 2000062.
26 Yan Y, Zou Z, Sun Y, Li X, Xu K-F, Wei Y, et al. Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model. Cell research. 2013; 23(2):300-302.   DOI
27 Yang Y, Lu Q, Liu M, Wang Y, Zhang A, Jalali N, et al. Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China. MedRxiv, 2020.
28 Yip HK, Chang YC, Wallace CG, Chang LT, Tsai TH, Chen YL, et al. Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury. Journal of pineal research. 2013; 54(2): 207-221.   DOI
29 Zheng BJ, Guan Y, Wong KH, Zhou J, Wong KL, Young BWY, et al. SARS-related virus predating SARS outbreak, Hong Kong. Emerging infectious diseases. 2004; 10(2):176.   DOI
30 Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. New England Journal of Medicine. 2007; 357(14):1450-1451.   DOI
31 Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733.   DOI
32 Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses-drug discovery and therapeutic options. Nature reviews Drug discovery. 2016; 15(5):327.   DOI
33 Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3): 1560-7917.
34 Choy M. Pharmaceutical approval update. Pharmacy and Therapeutics. 2016; 41(5): 288.
35 Chu C, Cheng V, Hung I, Wong M, Chan K, Chan K, et al. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. 2004; 59(3): 252-256.   DOI
36 Corman VM, Ithete NL, Richards LR, Schoeman MC, Preiser W, Drosten C, et al. Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat. Journal of virology. 2014; 88(19): 11297-11303.   DOI
37 Coutard B, Valle C, de Lamballerie X, Canard B, Seidah N, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral research. 2020; 176: 104742.   DOI
38 da Cunha Pedrosa AM, Weinlich R, Mognol GP, Robbs BK, de Biaso Viola JP, Campa A, et al. Melatonin protects CD4+ T cells from activation-induced cell death by blocking NFAT-mediated CD95 ligand upregulation. The Journal of Immunology. 2010; 184(7): 3487-3494.   DOI
39 Debing Y, Emerson SU, Wang Y, Pan Q, Balzarini J, Dallmeier K, et al. Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon. Antimicrobial agents and chemotherapy. 2014; 58(1): 267-273.   DOI
40 De Clercq E. New Nucleoside Analogues for the Treatment of Hemorrhagic Fever Virus Infections. Chemistry-An Asian Journal. 2019; 14(22): 3962-3968.   DOI
41 Duan K, Liu B, Li C, Zhang H, Yu T, Qu J, et al. Effectiveness of convalescent plasma therapy in severe COVID-19 patients. Proceedings of the National Academy of Sciences. 2020; 117(17): 9490-9496.   DOI
42 Graham RL, Donaldson EF, Baric RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nature Reviews Microbiology. 2013; 11(12): 836-848.   DOI
43 Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis. Coronaviruses. 2015;1-23
44 Fung TS, Liu DX. Human Coronavirus: Host-Pathogen Interaction. Annual review of microbiology. 2019; 73: 529-557.   DOI
45 Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020; 14(1): 72-73.   DOI
46 Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv, 2020.
47 Guarner J. Three emerging coronaviruses in two decades: the story of SARS, MERS, and now COVID-19. Am J Clin Pathol. 2020; 153(4): 420-421.   DOI
48 Hardeland R. Melatonin and inflammation-Story of a double-edged blade. Journal of pineal research. 2018; 65(4): e12525.   DOI
49 Ling Y, Li ZZ, Zhang JF, Zheng XW, Lei ZQ, Chen RY, et al. MicroRNA-494 inhibition alleviates acute lung injury through Nrf2 signaling pathway via NQO1 in sepsis-associated acute respiratory distress syndrome. Life sciences. 2018; 210: 1-8.   DOI
50 Li W, Shi Z, Yu M, Ren W, Smith C, Epstein JH, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science. 2005; 310(5748): 676-679.   DOI
51 Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung S-m, et al. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. Journal of clinical medicine. 2020; 9(2): 538.   DOI
52 Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chinese medical journal, 2020.
53 Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020; 395(10224): 565-574.   DOI
54 Mahase E. China coronavirus: WHO declares international emergency as death toll exceeds 200. Bmj. 2020; 368: m408.   DOI
55 Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, et al. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. The Journal of infectious diseases. 2015; 211(1): 80-90.   DOI
56 Huang SH, Cao XJ, Liu W, Shi XY, Wei W. Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. Journal of pineal research. 2010; 48(2): 109-116.   DOI
57 He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, et al. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochemical and biophysical research communications. 2004; 324(2): 773-781.   DOI
58 Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. New England Journal of Medicine, 2020.
59 Howlader N, Mariotto AB, Besson C, Suneja G, Robien K, Younes N, et al. Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era. Cancer. 2017; 123(17): 3326-3334.   DOI
60 Malik YS, Sircar S, Bhat S, Sharun K, Dhama K, Dadar M, et al. Emerging novel coronavirus (2019-nCoV)-current scenario, evolutionary perspective based on genome analysis and recent developments. Veterinary quarterly. 2020; 40(1): 68-76.   DOI
61 Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW, et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clinical Infectious Diseases. 2011; 52(4): 447-456.   DOI
62 Huynh J, Li S, Yount B, Smith A, Sturges L, Olsen JC, et al. Evidence supporting a zoonotic origin of human coronavirus strain NL63. Journal of virology. 2012; 86(23): 12816-12825.   DOI
63 Junaid A, Tang H, van Reeuwijk A, Abouleila Y, Wuelfroth P, van Duinen V, et al. Ebola Hemorrhagic Shock Syndrome-on-a-Chip. iScience. 2020; 23(1): 100765.   DOI
64 Meng L, Hua F, Bian Z. Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine. Journal of Dental Research. 2020; 99(5): 481-487.   DOI
65 Meyer B, Drosten C, Muller MA. Serological assays for emerging coronaviruses: challenges and pitfalls. Virus research. 2014; 194: 175-183.   DOI
66 Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395(10223): 497-506.   DOI
67 Kan B, Wang M, Jing H, Xu H, Jiang X, Yan M, et al. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. Journal of virology. 2005; 79(18): 11892-11900.   DOI
68 Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochemical and biophysical research communications. 2004; 323(1): 264-268.   DOI
69 Ko J-H, Seok H, Cho SY, Ha YE, Baek JY, Kim SH, et al. Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience. Antiviral therapy. 2018; 23(7): 617-622.   DOI
70 Mukherjee P, Desai P, Ross L, White EL, Avery MA. Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits. Bioorganic & medicinal chemistry.2008; 16(7): 4138-4149.   DOI
71 Pronker ES, Weenen TC, Commandeur H, Claassen EH, Osterhaus AD. Risk in vaccine research and development quantified. PloS one. 2013; 8(3).
72 Que T, Wong V, Yuen K. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J. 2003; 9(6): 399-406.
73 Reiter RJ, Ma Q, Sharma R. Melatonin in mitochondria: mitigating clear and present dangers. Physiology. 2020a; 35(2): 86-95.   DOI
74 Reiter RJ, Ma Q, Sharma R. Treatment of Ebola and other infectious diseases: melatonin "goes viral". Melatonin Research. 2020b; 3(1): 43-57.   DOI
75 Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020; 109(102433): 26.
76 Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England Journal of Medicine. 2020; 382(10): 970-971.   DOI
77 Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases. The Lancet infectious diseases. 2003; 3(11): 722-727.   DOI
78 Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. Journal of Microbiology, Immunology and Infection, 2020.
79 Kono M, Tatsumi K, Imai AM, Saito K, Kuriyama T, Shirasawa H. Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK. Antiviral research. 2008; 77(2): 150-152.   DOI
80 Lau SK, Li KS, Tsang AK, Lam CS, Ahmed S, Chen H, et al. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. Journal of virology. 2013; 87(15): 8638-8650.   DOI
81 Li F. Structure, function, and evolution of coronavirus spike proteins. Annual review of virology. 2016; 3: 237-261.   DOI
82 Lei J, Li J, Li X, Qi X. CT Imaging of the 2019 Novel Coronavirus (2019-nCoV) Pneumonia. Radiology. 2020; 295(1): 31.
83 Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA. Incubation periods of acute respiratory viral infections: a systematic review. The Lancet infectious diseases. 2009; 9(5): 291-300.   DOI
84 Leyssen P, Balzarini J, De Clercq E, Neyts J. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase. Journal of virology. 2005; 79(3): 1943-1947.   DOI
85 Li J, Zhang C, Shan H. Advances in mRNA vaccines for infectious diseases. Frontiers in Immunology. 2019; 10: 594.   DOI
86 Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N Engl J Med. 2020b; 382(13): 1199-1207.   DOI
87 Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A New insights into the antiviral effects of chloroquine. edn. The Lancet Infect Dis. 2006; 6(2):67-9.   DOI
88 Shi Z, Hu Z. A review of studies on animal reservoirs of the SARS coronavirus. Virus research. 2008; 133(1): 74-87.   DOI
89 Shang Y, Xu SP, Wu Y, Jiang Y, Wu ZY, Yuan S, et al. Melatonin reduces acute lung injury in endotoxemic rats. Chinese medical journal. 2009; 122(12): 1388-1393.   DOI
90 Sheahan TP, Sims AC, Graham RL, Menachery VD, Gralinski LE, Case JB, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Science translational medicine.2017; 9(396).
91 Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). The Indian Journal of Pediatrics. 2020; 87(4): 281-286.   DOI
92 So LK, Lau AC, Yam LY, Cheung TM, Poon E, Yung RW, et al. Development of a standard treatment protocol for severe acute respiratory syndrome. The Lancet. 2003; 361(9369): 1615-1617.   DOI
93 Sola I, Almazan F, Zuniga S, Enjuanes L. Continuous and discontinuous RNA synthesis in coronaviruses. Annual review of virology. 2015; 2: 265-288.   DOI
94 Sun CK, Lee FY, Kao YH, Chiang HJ, Sung PH, Tsai TH, et al. Systemic combined melatonin-mitochondria treatment improves acute respiratory distress syndrome in the rat. Journal of pineal research. 2015; 58(2): 137-150.   DOI
95 Van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, Baize S, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. New England Journal of Medicine. 2016; 374(1): 33-42.   DOI
96 Varia M, Wilson S, Sarwal S, McGeer A, Gournis E, Galanis E. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. Cmaj. 2003; 169(4): 285-292.